AU2289601A - The use of procyanidins in the modulation of cytokine gene expression and protein secretion - Google Patents

The use of procyanidins in the modulation of cytokine gene expression and protein secretion

Info

Publication number
AU2289601A
AU2289601A AU22896/01A AU2289601A AU2289601A AU 2289601 A AU2289601 A AU 2289601A AU 22896/01 A AU22896/01 A AU 22896/01A AU 2289601 A AU2289601 A AU 2289601A AU 2289601 A AU2289601 A AU 2289601A
Authority
AU
Australia
Prior art keywords
procyanidins
modulation
gene expression
protein secretion
cytokine gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22896/01A
Inventor
Harold H. Schmitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mars Inc
Original Assignee
Mars Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mars Inc filed Critical Mars Inc
Publication of AU2289601A publication Critical patent/AU2289601A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/42—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G1/426—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
AU22896/01A 1999-12-21 2000-12-21 The use of procyanidins in the modulation of cytokine gene expression and protein secretion Abandoned AU2289601A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46875399A 1999-12-21 1999-12-21
US09468753 1999-12-21
PCT/US2000/035059 WO2001045726A2 (en) 1999-12-21 2000-12-21 The use of procyanidins in the modulation of cytokine gene expression and protein secretion

Publications (1)

Publication Number Publication Date
AU2289601A true AU2289601A (en) 2001-07-03

Family

ID=23861094

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22896/01A Abandoned AU2289601A (en) 1999-12-21 2000-12-21 The use of procyanidins in the modulation of cytokine gene expression and protein secretion

Country Status (2)

Country Link
AU (1) AU2289601A (en)
WO (1) WO2001045726A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1314420A1 (en) * 2001-11-23 2003-05-28 Cognis Iberia, S.L. Anti-ageing composition
US20040052928A1 (en) 2002-09-06 2004-03-18 Ehud Gazit Peptides and methods using same for diagnosing and treating amyloid-associated diseases
FR2838055B1 (en) * 2002-04-05 2006-06-09 Cep NOVEL USE OF A COCOA EXTRACT AND COSMETIC AND / OR DERMATOLOGICAL COMPOSITIONS THEREFOR
CA2507704A1 (en) * 2002-12-02 2004-06-17 Mars, Incorporated Flavanols and procyanidins promote homeostasis
US7491699B2 (en) 2002-12-09 2009-02-17 Ramot At Tel Aviv University Ltd. Peptide nanostructures and methods of generating and using the same
WO2004060791A1 (en) 2003-01-07 2004-07-22 Ramot At Tel Aviv University Ltd. Peptide nanostructures encapsulating a foreign material and method of manufacturing same
JP5137400B2 (en) 2003-06-30 2013-02-06 テル アヴィヴ ユニヴァーシティ フューチャー テクノロジー ディヴェロップメント エル．ピー． Peptides for diagnosing and treating amyloid-related diseases, antibodies thereto, and methods of use thereof
WO2006006172A2 (en) * 2004-07-15 2006-01-19 Ramot At Tel Aviv University Ltd. Use of anti-amyloid agents for treating and typing pathogen infections
WO2006013552A2 (en) 2004-08-02 2006-02-09 Ramot At Tel Aviv University Ltd. Articles of peptide nanostructures and method of forming the same
US7732479B2 (en) 2004-08-19 2010-06-08 Tel Aviv University Future Technology Development L.P. Compositions for treating amyloid associated diseases
US10004828B2 (en) 2005-10-11 2018-06-26 Romat at Tel-Aviv University Ltd. Self-assembled Fmoc-ff hydrogels
EP1913821A1 (en) * 2006-10-20 2008-04-23 Kraft Foods R & D, Inc. Zweigniederlassung München Polyphenol-rich extract from plant material
US9114114B2 (en) 2007-06-21 2015-08-25 Mars, Inc. Edible products having a high cocoa polyphenol content and improved flavor and the milled cocoa extracts used therein
EP2598206B1 (en) * 2010-07-28 2021-09-22 Indus Biotech Private Limited A method of managing broncho-constrictive condition
AR083885A1 (en) 2010-11-15 2013-03-27 Univ Ramot ANALOGS OF DIPEPTIDES FOR THE TREATMENT OF AFFECTIONS ASSOCIATED WITH THE FORMATION OF AMILOID FIBRILLES
TWI421072B (en) * 2011-08-19 2014-01-01 Indus Biotech Private Ltd A method of managing broncho-constrictive condition
US20150335695A1 (en) * 2014-05-25 2015-11-26 Tu Song-Anh Nguyen Therapeutic Nutritional Supplement to Alleviate Symptoms of COPD and Delay the Progression Thereof
WO2016046375A1 (en) * 2014-09-25 2016-03-31 Institut National De La Sante Et De La Recherche Medicale (Inserm) Theobroma cacao extract for use in the treatment or prevention of receptor tyrosine kinases related disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554645A (en) * 1994-10-03 1996-09-10 Mars, Incorporated Antineoplastic cocoa extracts and methods for making and using the same
US6015913A (en) * 1996-09-06 2000-01-18 Mars, Incorporated Method for producing fat and/or solids from cocoa beans

Also Published As

Publication number Publication date
WO2001045726A2 (en) 2001-06-28
WO2001045726A3 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
AU2289601A (en) The use of procyanidins in the modulation of cytokine gene expression and protein secretion
AU1926001A (en) Novel human protein kinases and protein kinase-like enzymes
AU7907300A (en) Novel combination of loteprednol and antihistamines
AU4289100A (en) Dihydropyrimidines and their use in the treatment of hepatitis
AU1164601A (en) Therapeutic use and formulation
AU5800399A (en) Polish composition and method of use
AU2002246808A1 (en) Human nucleic acids and polypeptides and methods of use thereof
AU6394400A (en) Secreted proteins and uses thereof
AU6294700A (en) Anti-idiotypic antibodies of fibroblast growth factors and their use as medicines
AU3501700A (en) Human endokine alpha and methods of use
AU2001261375A1 (en) Human caspase-12 materials and methods
AU5750200A (en) Secreted proteins and uses thereof
AU2002312373A1 (en) Structural and cytoskeleton-associated proteins
AU1456899A (en) Human protein kinase and kinase inhibitors
AU1894601A (en) Novel gene and use thereof
AU3382800A (en) Secreted proteins and uses thereof
AU2399601A (en) Novel tachykinin-like polypeptides and use thereof
AU3890200A (en) Novel porcine protein and uses thereof
AU2136401A (en) P450rai-2 and related proteins
AU4997700A (en) Disposable absorbent article combining low viscosity liquid handling and high viscosity liquid handling
WO2000069885A8 (en) Secreted proteins and uses thereof
AU1190801A (en) Secreted proteins and uses thereof
AU2669201A (en) Taccalonolides and their use
AU7684000A (en) Interferon complex and medicinal use thereof
AU5634400A (en) Shank proteins and methods of use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase